España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Dyne Therapeutics
DYN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$23.99
-0.31
-1.28%
At close: -
$23.99
0.00
0.00%
After Hours: Dec 20, 4:37 PM EDT
Get Report
Comment
Dyne Therapeutics (DYN) Forecast
News
Earnings
Dyne Therapeutics (DYN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Dyne Therapeutics (NASDAQ:DYN) Stock
Dyne Therapeutics Stock (NASDAQ: DYN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 13, 2024
Baird Initiates Coverage On Dyne Therapeutics...
Benzinga Newsdesk
Friday, December 06, 2024
Dyne Therapeutics Director Kersten Dirk Sells...
Benzinga Newsdesk
Tuesday, November 26, 2024
RBC Capital Initiates Coverage On Dyne Therap...
Benzinga Newsdesk
Wednesday, November 13, 2024
Chardan Capital Maintains Buy on Dyne Therape...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Dyne Th...
Benzinga Newsdesk
Tuesday, November 12, 2024
Dyne Therapeutics shares are trading higher. ...
Benzinga Newsdesk
Dyne Therapeutics' Cash, Cash Equivalents And...
Benzinga Newsdesk
Dyne Therapeutics Q3 2024 GAAP EPS $(0.96) Mi...
Benzinga Newsdesk
Thursday, October 24, 2024
Dyne Therapeutics shares are trading lower af...
Benzinga Newsdesk
JP Morgan Downgrades Dyne Therapeutics to Neu...
Benzinga Newsdesk
Tuesday, October 22, 2024
Looking Into Dyne Therapeutics's Recent Short Interest
Benzinga Insights
Monday, September 30, 2024
Peering Into Dyne Therapeutics's Recent Short Interest
Benzinga Insights
Monday, September 23, 2024
Piper Sandler Reiterates Overweight on Dyne T...
Benzinga Newsdesk
Wednesday, September 04, 2024
HC Wainwright & Co. Reiterates Buy on Dyne Th...
Benzinga Newsdesk
Tuesday, September 03, 2024
Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
Avi Kapoor
Oppenheimer Reiterates Outperform on Dyne The...
Benzinga Newsdesk
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
Vandana Singh
Nasdaq Dips Over 2%; US Construction Spending Falls In July
Avi Kapoor
Dow Tumbles 1%; ISM Manufacturing PMI Misses Estimates
Avi Kapoor
Boeing, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Dyne Therapeutics shares are trading lower. T...
Benzinga Newsdesk
Dyne Therapeutics Announced New Clinical Data...
Benzinga Newsdesk
Friday, August 16, 2024
Stifel Maintains Buy on Dyne Therapeutics, Ra...
Benzinga Newsdesk
Thursday, August 15, 2024
Guggenheim Maintains Buy on Dyne Therapeutics...
Benzinga Newsdesk
Wednesday, August 14, 2024
Morgan Stanley Maintains Overweight on Dyne T...
Benzinga Newsdesk
Tuesday, August 13, 2024
Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday?
Piero Cingari
Piper Sandler Maintains Overweight on Dyne Th...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Dyne The...
Benzinga Newsdesk
Monday, August 12, 2024
Dyne Therapeutics Expects Cash & Equivalents ...
Benzinga Newsdesk
Dyne Therapeutics Q2 2024 GAAP EPS $(0.70) Be...
Benzinga Newsdesk
Sunday, July 14, 2024
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
Lekha Gupta
Tuesday, July 09, 2024
Dyne Therapeutics shares are trading higher a...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Dyne Therap...
Benzinga Newsdesk
Thursday, June 13, 2024
Dyne Therapeutics DYNE-302 Exhibited Prolonge...
Benzinga Newsdesk
Wednesday, June 12, 2024
Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Piero Cingari
Wednesday, May 22, 2024
Modine Manufacturing Posts Mixed Q4 Results, Joins Viasat, Lululemon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Reported Earlier, Dyne Therapeutics Prices $3...
Benzinga Newsdesk
Tuesday, May 21, 2024
Chardan Capital Maintains Buy on Dyne Therape...
Benzinga Newsdesk
Monday, May 20, 2024
Dyne Therapeutics Announces $300M Public Offe...
Benzinga Newsdesk
Why Is Dyne Therapeutics Stock Soaring On Monday?
Vandana Singh
Jefferies Maintains Buy on Dyne Therapeutics,...
Benzinga Newsdesk
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Dyne The...
Benzinga Newsdesk
Market-Moving News for May 20th
Benzinga Newsdesk
Dyne Therapeutics shares are higher after the...
Benzinga Newsdesk
Dyne Therapeutics Announced Clinical Data Fro...
Benzinga Newsdesk
Reported Sunday, Dyne Therapeutics Announces ...
Benzinga Newsdesk
Monday, May 06, 2024
Chardan Capital Maintains Buy on Dyne Therape...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch